E2F3 and lung carcinoma: Moreover, E2F3, a downstream signaling molecule of CSF-1, has been found to increase expression of E2F3 in prostate cancer, ovarian cancer, and lung cancer, and the expression of E2F3 in TAMs can promote lung metastasis of tumors (111).